RediClinic set to offer H1N1 vaccine, FluMist
HOUSTON RediClinic is reinforcing its role as a local resource for prevention and treatment of seasonal illnesses by providing FluMist nasal flu vaccine and gearing up to offer the H1N1 vaccine when it becomes available.
As previously reported by Drug Store News, the retail-based clinic operator is offering FluMist in its Houston and Austin locations.
In addition, the clinics expect to offer the H1N1 vaccine when it is projected to become available in mid-October. For those patients experiencing flu-like symptoms, RediClinic offers diagnostic tests and treatment options to help them get healthy as quickly as possible.
“All of our clinicians are prepared to share information and advice with patients interested in learning how to prevent these illnesses, and our clinics are open seven days a week and after school and work on weekdays to ensure that patients have access to care when they need it most,” stated Nancy Ross, RediClinic nurse practitioner.
Study finds certain diabetes drugs may cause bone fractures
NEW YORK A certain class of diabetes drugs may put patients at higher risk of bone fractures, according to a study published in the online edition of the journal PLoS Medicine.
Researchers at the London School of Hygiene and Tropical Medicine, in the United Kingdom, used data from a database of more than 6 million British patients, using data from 1,819 patients aged 40 and older who had experienced a bone fracture while taking at least one drug called a thiazolidinedione.
Taking age and the resulting higher risk of fractures into account, the researchers found that patients had fractures at 1.43 times the rate while taking the drugs as when they didn’t take them. Among patients taking the drugs for four years or more, the rate was twofold. Though the study’s findings suggest an association between the drugs and higher risk of fractures, the researchers cautioned against jumping to conclusions based on them.
“These findings do not prove that thiazolidinediones cause fractures because, despite the self-controlled case-series design of this study, it remains possible that the people who have fractures share some unknown characteristic that affects their chances of breaking a bone,” the researchers wrote.
Thiazolidinediones, also known as glitazones include drugs such as GlaxoSmithKline’s Avandia (rosiglitazone) and Takeda Pharmaceuticals’ Actos (pioglitazone), both of which were included in the study.
All cases of gestational diabetes should be treated, study finds
NEW YORK As the percentage of women who are overweight increases, so have cases of a form of diabetes that occurs in pregnant women and can put their babies at risk of metabolic disorders.
According to a study of 958 women, six to eight months pregnant with mild gestational diabetes, published Wednesday in the New England Journal of Medicine, all women with the condition should receive treatment for it. The women were broken into two groups, one that received no treatment and one that received counseling on diet and monitoring of glucose and, in some cases, insulin.
Most babies were born with normal weights, but 14.5% in the group that received no treatment were too large, compared with 7.1% of the babies in the treatment group, who also were less likely to experience birth trauma or have to be delivered by C-section.